Table 1 The expression of miR-101-3p, and the contents of PGI, PGII and CEA in the serum of patients with atrophic gastritis (AG) and gastric cancer (GC), and healthy volunteers (Normal control)
From: Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer
Index | Normal control (n = 50) | AG (n = 61) | GC (n = 86) |
|---|---|---|---|
Sex | |||
Male, N (%) | 26 (52) | 33 (54.1) | 36 (41.9) |
Female, N (%) | 24 (48) | 28 (45.9) | 50 (58.1) |
Age (years) | 45.150 ± 1.400 | 46.220 ± 1.600 | 60.110 ± 2.100 |
miR-101-3p | 1.000 ± 0.145 | 0.816 ± 0.068* | 0.730 ± 0.064*# |
PGI (μg/l) | 75.460 ± 12.480 | 66.770 ± 9.240* | 58.490 ± 11.950*# |
PGII (μg/l) | 11.000 ± 3.380 | 14.870 ± 9.090* | 17.790 ± 16.010*# |
PGI/II ratio | 7.350 ± 1.970 | 5.440 ± 2.040* | 4.220 ± 1.710*# |
CEA (μg/l) | 1.850 ± 0.730 | 2.310 ± 1.080 | 3.660 ± 1.380*# |